Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
- Resource Type
- Source
- The Lancet. Oncology
- Subject
Adult Male Immunogenicity, Vaccine Oncology Neoplasms Comment Immunization, Secondary Humans Female Middle Aged BNT162 Vaccine Aged - Language
- ISSN
- 1474-5488